Peninsula drug company Tricida cutting more than half of staff after clinical trial failure


The company earlier this month said it was looking at "strategic alternatives," including a sale in whole or in part.

Previous Health systems in the red: Advocate Aurora posts $911M loss, ProHealth loses $100M
Next With acquisition, vision and deep pockets, Kriya Therapeutics eyes new day for gene therapy